Design Therapeutics
DSGN
DSGN
100 hedge funds and large institutions have $172M invested in Design Therapeutics in 2024 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 34 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.24% less ownership
Funds ownership: 56.81% → 56.57% (-0.24%)
12% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 34
90% less call options, than puts
Call options by funds: $18K | Put options by funds: $175K
Holders
100
Holding in Top 10
2
Calls
$18K
Puts
$175K
Top Buyers
| 1 | +$4.02M | |
| 2 | +$3.75M | |
| 3 | +$3.28M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$1.46M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$523K |
Top Sellers
| 1 | -$4.38M | |
| 2 | -$2.17M | |
| 3 | -$1.77M | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$1.41M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.05M |